Menu
Log in


Canadian Society of

Pharmacology and Therapeutics

Log in
Welcome!

Thank you for being a valued member. Take advantage of all the benefits your membership includes and don't forget to renew.

Log in

CSPT Member log-In / Reset Password / View & Edit Profile

For laptop and desktop users, click the blue person icon located on the left or on top right of your screen.

For mobile (phone) and tablet users, click the black arrow icon located on the top right of your screen.


CSPT membership APP for your iphone, ipad, Android device, and Chromebook.

Apple APP Store


Upcoming events

    • Friday, December 08, 2023
    • 12:00 PM - 1:00 PM
    • Virtual Zoom Meeting
    Register


    Join us on Friday, December 8th to hear novel insights and future directions from two junior faculty CSPT members! 

    Dr. Britt Drögemöller is an Assistant Professor in the Department of Biochemistry & Medical Genetics at the University of Manitoba and holds a Tier 2 Canada Research Chair in Pharmacogenomics and Precision Medicine. Dr. Drögemöller received her PhD from Stellenbosch University in South Africa in 2013, and continued her training in pharmacogenomics and precision medicine at the University of British Columbia, where she completed a postdoctoral fellowship at the Canadian Pharmacogenomics Network for Drug Safety. Dr. Drögemöller's research focuses on using large-scale genomic and computational analysis to guide the development of novel treatment strategies that offer maximum benefit and minimal harm. www.drogemollerlab.com

    Dr. Thomas (Tom) Velenosi received his PhD in pharmacology and toxicology from Western University. As a graduate student, he used state-of-the-art metabolomics analysis to identify a novel metabolic biomarker of kidney function in patients with chronic kidney disease. He then joined the Laboratory of Metabolism at the National Cancer Institute (National Institutes of Health) as a postdoctoral fellow, which was supported by the Canadian Institutes of Health Research Fellowship. There, he began his research vision by developing a novel approach to using metabolic biomarkers as a path for precision therapy and improving outcomes for cancer patients. He is currently an assistant professor in the UBC Faculty of Pharmaceutical Sciences. https://pharmsci.ubc.ca/directory/thomas-j-velenosi

Sponsors & Partners section

Canadian Society of Pharmacology and Therapeutics

email: info@pharmacologycanada.org

Copyright © 2020 CSPT. All rights reserved.

Powered by Wild Apricot Membership Software